DEPAKINE CHRONO 500 mg, film-coated tablet scored with extended release 30 tablets
Brand page: Depakine, Depakine Chrono (valproic acid (sodium valproate)) — all forms and strengths in France
Active ingredients: Valproic acid, Sodium valproate
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet scored with extended release30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DEPAKINE CHRONO 500 mg, comprimé pelliculé sécable à libération prolongée
- Pharmaceutical form
- comprimé pelliculé sécable à libération prolongée
- Route of administration
- orale
- Presentation description
- tube(s) polypropylène de 30 comprimé(s)
- Marketing authorisation holder
- DIFARMED (ESPAGNE)
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Jun 2024
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Requires special monitoring during treatment
- Initial prescription by a specialist
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69899585CIP74900547CIP133400949005475Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SODIUM (VALPROATE DE)comprimé | 333 mg · un comprimé | SA |
| ACIDE VALPROÏQUEcomprimé | 145 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.